Johnson & Johnson | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights
Johnson & Johnson is a focused healthcare company headquartered in New Brunswick, NJ, specializing in Innovative Medicine, Medical...
Johnson & Johnson is a focused healthcare company headquartered in New Brunswick, NJ, specializing in Innovative Medicine, Medical Devices & Diagnostics, and Pharmaceuticals. The company is dedicated to tackling complex health challenges through innovation in science and technology, aiming to improve patient care and health outcomes globally.
Website
Headquarters
New Brunswick, NJ
Size
10,001+ employees
Industry
Hospitals and Health Care
Specialities
Health Care, Medical Devices & Diagnostics, Pharmaceuticals
🛍️ Johnson & Johnson Product and Pricing News →
👔 Johnson & Johnson CEO, Management and Leadership Team →
⚔️ Johnson & Johnson Alternatives and Competitors →
💼 Johnson & Johnson Hiring and Layoffs →
🤖 Johnson & Johnson Developer, Integration and Automation News →
📈 Johnson & Johnson Financials, Fundraising and Valuation News →
🛍️ Johnson & Johnson Product and Pricing News
- On November 11, 2024, Johnson & Johnson announced that the FDA granted Breakthrough Therapy designation to nipocalimab for treating moderate-to-severe Sjögren's disease.
- Johnson & Johnson has proposed a $6.4 billion settlement plan to resolve the ongoing talc litigation.
- Johnson & Johnson's talc-based baby powder lawsuit progress is expected to be decided by a Houston judge in January 2025.
- On November 7, 2024, Johnson & Johnson MedTech unveiled new joint reconstruction solutions at the AAHKS Annual Meeting, showcasing advanced surgical techniques and data-driven technologies.
- On November 7, 2024, Johnson & Johnson MedTech received FDA approval for the VARIPULSE™ Platform to treat drug refractory paroxysmal Atrial Fibrillation.
- Thousands are suing Ethicon, a Johnson & Johnson subsidiary, over hernia mesh products that allegedly cause serious health issues, with potential settlements ranging from $60,000 to $100,000.
- Johnson & Johnson is collaborating with Bristol Myers Squibb to present data on milvexian, an investigational agent for thrombosis management, at the American Heart Association Scientific Sessions 2024.
- Johnson & Johnson will attend the Swiss Oncology & Hematology Congress 2024 in Basel on November 22 to meet potential product managers.
👔 Johnson & Johnson CEO, Management and Leadership Team
-
Business Unit Director Biosense Webster
ealeknaite@jnj.com -
Global Orthopaedics Finance Directorcfeddern@jnj.com
-
Director, Johnson and Johnson MedTechlmorrisey@jnj.com
-
Business Unit Director Ethicon CEE North (Poland, Lithuania, Latvia and Estonia )at Johnson & Johnsonksildre@jnj.com
-
Director, Venture Investmentsbimszennik@jnj.com
-
Country Director
-
IT Director
-
Director, Data Sciencessarraf@jnj.com
-
Former Chairman and CEO, Johnson & Johnsonagorsky@jnj.com
-
Founderahassett@jnj.com
-
Founder and Chief Executive Officerslewis@jnj.com
-
Tackling the world’s toughest health challenges as Chairman and Chief Executive Officer of Johnson & Johnsonjduato@jnj.com
-
Chief Learning Officer, Johnson & Johnsonshumbles@jnj.com
-
Chief Technology Officer & Global Vice President, Technology Servicesryeo@jnj.com
-
Chief Scientific Officer, J&J MedTechpschulam@jnj.com
-
Chief Procurement Officer, J&Jsmandapaty@jnj.com
-
Chief Digital Officer, Johnson & Johnson Vision ➜ Transformational Technology Leadermgaynor@jnj.com
-
SVP & Chief Audit Executiveedavis@jnj.com
-
Johnson & Johnsonhshimizu@jnj.com
-
Vice President Procurement, EMEAhsingh@jnj.com
-
President, Johnson&Company, Consultants in Executive Search and Organizationsjohnson@jnj.com
-
Senior Vice President Human Resources, Janssen EMEAlhruba@jnj.com
-
Vice Presidentasharma@jnj.com
-
Vice Presidentskavanagh@jnj.com
-
Former Vice-Presidentetoja@jnj.com
-
Vice Presidentgnovarro@jnj.com
-
CEO presso Medical Groupacestari@jnj.com
-
EVP, Chief Technical Operations & Risk Officer for Johnson & Johnsonkwengel@jnj.com
-
Global Chief Information Security Officer (CISO)gharbison@jnj.com
-
CFO Johnson & Johnson Innovative Medicine, Board Member, Strategic Advisor. Thought Leadership, Value Creation.dsnellgrove@jnj.com
-
CFO of Johnson & Johnson Medical Devices Chinajlu@jnj.com
-
CFO / Vice President of Finance: Enterprise Financial Planning & Analysisesipos@jnj.com
-
CFO & VP Finance, MedTech Chinadkim@jnj.com
-
CFO / Vice Presidentkjohnson@jnj.com
-
CFO
-
Retired CFO of Johnson & Johnsondcaruso@jnj.com
-
Chief Operating Officer, Double Bachelor's Degree Winnersvolem@jnj.com
⚔️ Johnson & Johnson Alternatives and Competitors
- Eli Lilly and Company |
- AbbVie |
- Merck & Co., Inc. |
- Pfizer |
- Bristol-Myers Squibb |
- Zoetis |
- Royalty Pharma |
- Jazz Pharmaceuticals |
- Corcept Therapeutics |
- Perrigo |
- Unilever |
- Procter & Gamble |
- Novartis AG |
- Roche Holding AG |
- AstraZeneca PLC |
- GlaxoSmithKline
💼 Johnson & Johnson Hiring and Layoffs
- Johnson & Johnson is currently seeking a Director Quality Systems in Switzerland.
- Johnson & Johnson is currently seeking a Communication and Public Affairs Leader in Australia.
- Johnson & Johnson is currently seeking a Clinical Lead in Innovative Medicine R&D, Clinical Development Immunology TA in Japan.
- Johnson & Johnson is currently seeking a Director, Regulatory Medical Writing in the United States.
- Johnson & Johnson is currently hiring for the position of Associate Director, Neuroscience Digital Health - Neurodegeneration in the United States.
- Johnson & Johnson is currently hiring for the position of Associate Director, Thought Leader Liaison, Gastroenterology in the United States.
- Johnson & Johnson is currently seeking a Strategy Engagement Lead in the United States.
- Johnson & Johnson is currently seeking an Associate Director, Laboratory Automation - Bioanalysis in the United States.
🤖 Johnson & Johnson Developer, Integration and Automation News
- Johnson & Johnson is collaborating with Stand Up To Cancer to research targeted therapies for AL amyloidosis, a rare disease linked to blood cancers, using teclistamab and daratumumab.
- Johnson & Johnson partnered with myAbility, Takeda, and Google to launch the first Disability Confidence Day in Switzerland on November 7, promoting workplace inclusion and accessibility.
📈 Johnson & Johnson Financials, Fundraising and Valuation News
- Shares of Johnson & Johnson entered oversold territory with an RSI reading of 29.5 after trading as low as $155.12 per share.
People also viewed
- Smith+Nephew |
- Medtronic |
- Enztec |
- Zimmer Biomet |
- Allegra Orthopaedics |
- Stryker |
- IuteCredit Moldova |
- Eleving Group
